A crucial aspect of regenerative treatment and drug discovery lies in the ability to grow human stem cell populations to sufficient amounts for therapeutic applications. Traditionally, constrained cell availability posed a significant obstacle to progress in these fields. Consequently, considerable work has been directed towards optimizing protocol